Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy
- CNBC: 6 events in the last 90 days
- Previous: 5 days earlier · Trump's oil and gas holdings gained up to $4.4M during Iran war, CNBC finds
What happened
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
Summary assembled by rule from the sources below